Brief: Imricor Medical Systems Receives Grant Approval For Visabl-Vt Trial
01/08/2023 02:25
Aug 1 (Reuters) - Imricor Medical Systems Inc IMR.AX :
* GRANTED APPROVAL FOR VISABL-VT TRIAL FROM MEDICAL ETHICS
REVIEW
COMMITTEE, LEIDEN HAGUE DELFT
Source text for Eikon: ID:nASXThlKT
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion